Clifton, NJ, United States of America

Antonino Focella

This inventor holds 3 USPTO granted patents. Top assignee: Hoffmann-La Roche Inc.. Active years: 1978-1982.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 41(Granted Patents)


Company Filing History:


Years Active: 1978-1982

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Antonino Focella: Innovator in Diagnostic Testing

Introduction

Antonino Focella is a notable inventor based in Clifton, NJ (US). He has made significant contributions to the field of diagnostic testing, holding a total of 3 patents. His work focuses on developing innovative methods for detecting substances in body fluids, which has important implications for medical diagnostics.

Latest Patents

Focella's latest patents include a diagnostic test for barbiturates. This invention involves aminoaryl esters and amino-lower alkyl amides of carboxy substituted barbiturates linked via an amide linkage to carboxylated latex polymers. These reagents are useful in a sensitive diagnostic test to detect the presence of barbiturates in body fluids. Another significant patent is an improved immunoassay for detecting the drug of abuse phencyclidine. This immunoassay utilizes an antibody elicited with a novel immunogen and a radiolabeled derivative of phencyclidine, enhancing the accuracy of drug detection.

Career Highlights

Focella is currently employed at Hoffmann-La Roche Inc., where he continues to innovate in the field of diagnostics. His work has contributed to advancements in medical testing and has the potential to improve patient care.

Collaborations

Some of his notable coworkers include John E Heveran and Sidney Teitel. Their collaboration has likely fostered an environment of innovation and creativity in their projects.

Conclusion

Antonino Focella's contributions to diagnostic testing exemplify the impact of innovation in healthcare. His patents reflect a commitment to improving medical diagnostics, which can lead to better health outcomes for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…